相关实验视频
Updated: Jun 21, 2026

18:30
Rat Mesentery Angiogenesis Assay
Published on: June 18, 2011
瘤缩因子α在便中作为肠道炎症的标志物
C P Braegger1, S Nicholls, S H Murch
1Department of Paediatric Gastroenterology, St Bartholomew's Hospital, London, UK.
Lancet (London, England)
|January 11, 1992
概括
在便中测量瘤亡因子α (TNFα) 可能提供一种简单的方法来监测炎症性肠病活动. 克罗恩病和性结肠炎的高水平表明它有可能成为可靠的生物标志物.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 评估炎症性肠病 (IBD) 活动是具有挑战性的.
- 目前用于测量IBD疾病活性的方法复杂且耗时.
- 瘤亡因子α (TNFα) 是IBD的关键炎症调解者.
研究的目的:
- 评估便TNFα度作为IBD疾病活动的潜在生物标志物.
- 为了比较有活跃IBD,不活跃IBD,腹和健康对照的儿童的便TNFα水平.
主要方法:
- 从患有活跃IBD,不活跃IBD,腹和健康对照的儿童收集了便样本.
- 在便中测量TNFα度,使用特定的测定方法.
- 进行了统计分析,以比较不同组的TNFα水平.
主要成果:
- 与对照组相比,便TNFα度在患有活跃克罗恩病 (中位数994 pg/g) 和活跃性结肠炎 (中位数276-5982 pg/g) 的儿童中显著升高.
- 在不活跃IBD的患者中,便TNFα水平降低到控制水平.
- 正常儿童和腹儿童的便TNFα度中位数较低 (分别为58 pg/g和45 pg/g).
结论:
- 便TNFα度是一种有希望的,简单的标记物,用于监测儿科炎症性肠病中的疾病活性.
- 这种非侵入性方法可能会简化IBD的管理.
- 进一步的研究可能会验证便TNFα作为IBD患者的常规临床工具.
相关概念视频
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

